{"id":852058,"date":"2025-05-16T17:33:33","date_gmt":"2025-05-16T21:33:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/"},"modified":"2025-05-16T17:33:33","modified_gmt":"2025-05-16T21:33:33","slug":"vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/","title":{"rendered":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">WASHINGTON<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 16, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &amp; Ophthalmology Summit 2025 in <span class=\"xn-location\">New York City<\/span> on <span class=\"xn-chron\">Wednesday, May 21, 2025<\/span>.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg\" title=\"Vanda Logo (PRNewsfoto\/Vanda Pharmaceuticals Inc.)\" alt=\"Vanda Logo (PRNewsfoto\/Vanda Pharmaceuticals Inc.)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>About Vanda Pharmaceuticals Inc.<\/b>\n      <\/p>\n<p>Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4430033-1&amp;h=3269774898&amp;u=http%3A%2F%2Fwww.vandapharma.com%2F&amp;a=www.vandapharma.com\" target=\"_blank\" rel=\"nofollow\">www.vandapharma.com<\/a>\u00a0and follow us on X @vandapharma.<\/p>\n<p>\n        <b><br \/>\n          <u>Corporate Contact:<br \/><\/u><br \/>\n        <\/b><br \/>\n        <span class=\"xn-person\">Kevin Moran<\/span><br \/>\n        <br \/>Senior Vice President, Chief Financial Officer and Treasurer <br \/>Vanda Pharmaceuticals Inc.<br \/>202-734-3400<br \/><a href=\"mailto:pr@vandapharma.com\" target=\"_blank\" rel=\"nofollow\">pr@vandapharma.com<\/a><\/p>\n<p>\n        <span class=\"xn-person\">Jim Golden<\/span> \/ <span class=\"xn-person\">Jack Kelleher<\/span> \/ <span class=\"xn-person\">Dan Moore<\/span><br \/>Collected Strategies <br \/><a href=\"mailto:VANDA-CS@collectedstrategies.com\" target=\"_blank\" rel=\"nofollow\">VANDA-CS@collectedstrategies.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH90303&amp;sd=2025-05-16\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro--ophthalmology-summit-2025-302458143.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro&#8211;ophthalmology-summit-2025-302458143.html<\/a><\/p>\n<p>SOURCE  Vanda Pharmaceuticals Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH90303&amp;Transmission_Id=202505161730PR_NEWS_USPR_____PH90303&amp;DateId=20250516\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire WASHINGTON , May 16, 2025 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &amp; Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com\u00a0and follow us on X @vandapharma. Corporate Contact: Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected Strategies VANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro&#8211;ophthalmology-summit-2025-302458143.html SOURCE &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-852058","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire WASHINGTON , May 16, 2025 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &amp; Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com\u00a0and follow us on X @vandapharma. Corporate Contact: Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected Strategies VANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro&#8211;ophthalmology-summit-2025-302458143.html SOURCE &hellip; Continue reading &quot;Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-16T21:33:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025\",\"datePublished\":\"2025-05-16T21:33:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/\"},\"wordCount\":145,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2090054\\\/VandaLogo_v1.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/\",\"name\":\"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2090054\\\/VandaLogo_v1.jpg\",\"datePublished\":\"2025-05-16T21:33:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2090054\\\/VandaLogo_v1.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2090054\\\/VandaLogo_v1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/","og_locale":"en_US","og_type":"article","og_title":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk","og_description":"PR Newswire WASHINGTON , May 16, 2025 \/PRNewswire\/ &#8212; Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &amp; Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025. About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com\u00a0and follow us on X @vandapharma. Corporate Contact: Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc.202-734-3400pr@vandapharma.com Jim Golden \/ Jack Kelleher \/ Dan MooreCollected Strategies VANDA-CS@collectedstrategies.com View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro&#8211;ophthalmology-summit-2025-302458143.html SOURCE &hellip; Continue reading \"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-16T21:33:33+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025","datePublished":"2025-05-16T21:33:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/"},"wordCount":145,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/","name":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg","datePublished":"2025-05-16T21:33:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2090054\/VandaLogo_v1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vanda-pharmaceuticals-announces-participation-in-the-mizuho-neuro-ophthalmology-summit-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro &amp; Ophthalmology Summit 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=852058"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/852058\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=852058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=852058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=852058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}